Eriko Simamura
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Clinical Biochemistry top 10%
- Metabolism and Genetic Disorders
Papers in
-
- ATP Synthase and ATPases Research 4
- Cancer therapeutics and mechanisms 2
- Heme Oxygenase-1 and Carbon Monoxide 2
-
- Bioactive Compounds and Antitumor Agents 6
- Co-authors
- Kei‐Ichi Hirai (12 shared papers)Hiroki Shimada (14 shared papers)Toshihisa Hatta (10 shared papers)Junko Koyama (6 shared papers)Jiehong Pan (5 shared papers)Nobuaki Higashi (4 shared papers)Shigeomi Shimizu (2 shared papers)Hiroki Otani (4 shared papers)
- Journals
- Archives of Biochemistry and Biophysics (2 papers)Anatomical Science International (2 papers)PLoS ONE (2 papers)British Journal of Haematology (1 paper)Endocrinology (1 paper)
- Partner nations
- JapanUnited StatesItaly
In The Last Decade
Eriko Simamura
22 papers receiving 522 citations
Peers
Comparison fields: 5 of 87
- Toxicology 69
- Clinical Biochemistry 37
- Molecular Biology 280
- Behavioral Neuroscience 13
- Cancer Research 49
Countries citing papers authored by Eriko Simamura
This map shows the geographic impact of Eriko Simamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eriko Simamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eriko Simamura more than expected).
Fields of papers citing papers by Eriko Simamura
This network shows the impact of papers produced by Eriko Simamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eriko Simamura. The network helps show where Eriko Simamura may publish in the future.
Co-authors
The 25 scholars most cited alongside Eriko Simamura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 72 | |
| 2 | 2006 | 68 | |
| 3 | 2008 | 66 | |
| 4 | 2010 | 40 | |
| 5 | 1998 | 31 | |
| 6 | 2008 | 28 | |
| 7 | 2015 | 28 | |
| 8 | 2009 | 22 | |
| 9 | 2006 | 19 | |
| 10 | 2002 | 17 | |
| 11 | 2015 | 15 | |
| 12 | 2005 | 15 | |
| 13 | 2011 | 15 | |
| 14 | 2001 | 15 | |
| 15 | 2003 | 14 | |
| 16 | 2008 | 13 | |
| 17 | 2012 | 13 | |
| 18 | 2002 | 12 | |
| 19 | 1997 | 10 | |
| 20 | Induced apoptosis and necrosis by 2-methylfuranonaphthoquinone in human cervical cancer HeLa cells. | 2000 | 9 |
About Eriko Simamura
Eriko Simamura is a scholar working on Molecular Biology, Toxicology, Immunology, Surgery and Oncology, having authored 22 papers that have together received 532 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (6 papers), ATP Synthase and ATPases Research (4 papers), Paraquat toxicity studies and treatments (4 papers), Reproductive System and Pregnancy (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Galectins and Cancer Biology (2 papers), Cancer therapeutics and mechanisms (2 papers) and Heme Oxygenase-1 and Carbon Monoxide (2 papers). The work is most often cited by research in Toxicology (69 citations), Clinical Biochemistry (37 citations), Molecular Biology (280 citations), Behavioral Neuroscience (13 citations) and Cancer Research (49 citations). Eriko Simamura has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Kei‐Ichi Hirai, Hiroki Shimada, Toshihisa Hatta, Junko Koyama, Jiehong Pan, Nobuaki Higashi, Shigeomi Shimizu, Hiroki Otani, Yukie Niwa and Tsutomu Takegami. Their work appears in journals such as Archives of Biochemistry and Biophysics, Anatomical Science International, PLoS ONE, British Journal of Haematology and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.